Arsenic-Containing Medicine Treatment Disturbed the Human Intestinal Microbial Flora.
Ontology highlight
ABSTRACT: Human intestinal microbiome plays vital role in maintaining intestinal homeostasis and interacting with xenobiotics. Few investigations have been conducted to understand the effect of arsenic-containing medicine exposure on gut microbiome. Most animal experiments are onerous in terms of time and resources and not in line with the international effort to reduce animal experiments. We explored the overall microbial flora by 16S rRNA genes analysis in fecal samples from acute promyelocytic leukemia (APL) patients treated with arsenic trioxide (ATO) plus all-trans retinoic acid (ATRA). Gut microbiomes were found to be overwhelmingly dominated by Firmicutes and Bacteroidetes after taking medicines containing arsenic in APL patients. The fecal microbiota composition of APL patients after
SUBMITTER: Li J
PROVIDER: S-EPMC10223770 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature
ACCESS DATA